Metric Finance
LearnFAQ
LearnFAQ

Learn / VCRE

NASDAQ: VCRE

Vicore Pharma Holding AB (VCRE) stock, explained like you're 5

Vicore Pharma Holding AB trades on the Nasdaq under the ticker VCRE. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 2.5 billion dollars.

Ticker
VCRE
Exchange
Nasdaq
Sector
Healthcare
Industry
Pharmaceutical Preparations
Size
Mid cap, about 2.5 billion dollars

Is Vicore Pharma Holding AB a small, medium or large cap company?

No. Vicore Pharma Holding AB is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 2.5 billion dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Vicore Pharma Holding AB makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves VCRE stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • Vicore Pharma’s CEO will join a New York panel on lung scarring and respiratory diseases (Stock Titan)
  • Vicore Pharma Holding AB (publ) (VCRE) Stock Price, News, Quote & History (Yahoo! Finance Canada)
  • symbol__ Stock Quote Price and Forecast (CNN)
  • Vicore Pharma Holding AB (VICO) Increases Shares Outstanding by 118,916 (TradingView)
  • Vicore Pharma Holding AB (publ) (VCRE) stock price, news, quote and history (Yahoo Finance Singapore)

Follow VCRE in your daily brief

Each trading day at 5 PM ET we post what happened to Vicore Pharma Holding AB and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow VCRE

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Vicore Pharma Holding AB stock

What does Vicore Pharma Holding AB do?

Vicore Pharma Holding AB trades on the Nasdaq under the ticker VCRE. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 2.5 billion dollars.

What is the ticker symbol for Vicore Pharma Holding AB?

Vicore Pharma Holding AB trades under the ticker VCRE on the Nasdaq.

What is Vicore Pharma Holding AB's market cap?

Vicore Pharma Holding AB is a mid cap stock with a market cap of about 2.5 billion dollars.

How does Vicore Pharma Holding AB make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves VCRE stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow VCRE stock every day?

Add VCRE to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow VCRE daily

A free brief on Vicore Pharma Holding AB and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • NVS · Novartis AG
  • AZN · Astrazeneca PLC
  • NVO · Novo Nordisk A S
  • VRTX · Vertex Pharmaceuticals Inc / Ma

Similar stocks

  • NVSNovartis AG
  • AZNAstrazeneca PLC
  • NVONovo Nordisk A S
  • VRTXVertex Pharmaceuticals Inc / Ma

Compare VCRE: VCRE vs NVS, VCRE vs AZN, VCRE vs NVO

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed